Nifedipine Tablet, Film Coated, Extended Release
Product Images NDC 60760-859

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 60760-859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

859-90 (Nifedipine 60760 859 90)

859-90 (Nifedipine 60760 859 90)
Nifedipine Extended-Release Tablets, USP 60 mg film-coated tablets, packaged quantity 90, labeled by St. Mary's Medical Park Pharmacy. The label includes NDC 60760-859-90 and states the product is Rx only, with storage instructions at controlled room temperature 15°-30° C (59°-86°F). Manufacturer is Ingenus Pharmaceuticals, LLC, Orlando, FL.*
FDA Label Image

01 (Image 01)

01 (Image 01)
Chemical structure diagram of nifedipine, showing its molecular arrangement including functional groups such as nitro, acetyl, and methoxy substituents attached to the dihydropyridine ring system.*
FDA Label Image

02 (Image 02)

02 (Image 02)
A data table comparing the percentage incidence of adverse effects in participants taking Nifedipine extended-release tablets (N=707) versus placebo (N=266). Adverse effects listed include headache, fatigue, dizziness, constipation, and nausea, with higher percentages generally reported in the Nifedipine group.*
FDA Label Image

03 (Image 03)

03 (Image 03)
A table presenting adverse effect percentages comparing Nifedipine Capsules and Placebo groups, listing effects such as dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, mood changes, palpitations, respiratory symptoms, and nasal congestion with corresponding participant numbers for each group.*
FDA Label Image

04 (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.